| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66f5691cc8767198f07bd9cd2dd356e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3681 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate |
2012-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d6f545663c7cffec69dd464e5ae9fce |
| publicationDate |
2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014251917-A1 |
| titleOfInvention |
Method for the treatment of multiple sclerosis |
| abstract |
The present invention relates to a treatment of multiple sclerosis, and includes the extracorporeal treatment of one or more body fluids, such as, for example blood, cerebral-spinal fluid, or lymphatic fluid. A treatment is applied to the extracorporeal body fluid where the treatment targets at least one target multiple sclerosis antigen in the body fluid. The treatment can include creating an antibody-antigen moiety and then removing antibody-antigen moiety from the body fluid before returning the body fluid to a patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10933070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292987-B2 |
| priorityDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |